Cargando…

Solids Turn into Liquids—Liquid Eutectic Systems of Pharmaceutics to Improve Drug Solubility

The low solubility of active pharmaceutical ingredients (APIs) is a problem in pharmaceutical development. Several methodologies can be used to improve API solubility, including the use of eutectic systems in which one of the constituents is the API. This class of compounds is commonly called Therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarraguça, Mafalda C., Ribeiro, Paulo R. S., Nunes, Cláudia, Seabra, Catarina Leal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8951776/
https://www.ncbi.nlm.nih.gov/pubmed/35337077
http://dx.doi.org/10.3390/ph15030279
_version_ 1784675468254904320
author Sarraguça, Mafalda C.
Ribeiro, Paulo R. S.
Nunes, Cláudia
Seabra, Catarina Leal
author_facet Sarraguça, Mafalda C.
Ribeiro, Paulo R. S.
Nunes, Cláudia
Seabra, Catarina Leal
author_sort Sarraguça, Mafalda C.
collection PubMed
description The low solubility of active pharmaceutical ingredients (APIs) is a problem in pharmaceutical development. Several methodologies can be used to improve API solubility, including the use of eutectic systems in which one of the constituents is the API. This class of compounds is commonly called Therapeutic Deep Eutectic Systems (THEDES). THEDES has been gaining attention due to their properties such as non-toxicity, biodegradability, and being non-expensive and easy to prepare. Since the knowledge of the solid liquid diagram of the mixture and the ideal eutectic point is necessary to ascertain if a mixture is a deep eutectic or just a eutectic mixture that is liquid at ambient temperature, the systems studied in this work are called Therapeutic Liquid Eutectic Systems (THELES). Therefore, the strategy proposed in this work is to improve the solubility of chlorpropamide and tolbutamide by preparing THELES. Both APIs are sulfonylurea compounds used for the treatment of type 2 diabetes mellitus and have low solubility in water. To prepare the THELES, several coformers were tested, namely, tromethamine, L(+)-arginine, L-tryptophan, citric acid, malic acid, ascorbic acid, and p-aminobenzoic acid, in molar ratios of 1:1 and 1:2. To improve viscosity, water was added in different molar ratios to all systems. THELES were characterized by mid-infrared spectroscopy (MIR), and differential scanning calorimetry. Their viscosity, solubility, and permeability were also determined. Their stability at room temperature and 40 °C was accessed by MIR. Cytocompatibility was performed by metabolic activity and cell lysis evaluation, according to ISO10993-5:2009, and compared with the crystalline APIs. THELES with TRIS were successfully synthesized for both APIs. Results showed an increased solubility without a decrease in the permeability of the APIs in the THELES when compared with the pure APIs. The THELES were also considered stable for 8 weeks at ambient temperature. The cells studied showed that the THELES were not toxic for the cell lines used.
format Online
Article
Text
id pubmed-8951776
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-89517762022-03-26 Solids Turn into Liquids—Liquid Eutectic Systems of Pharmaceutics to Improve Drug Solubility Sarraguça, Mafalda C. Ribeiro, Paulo R. S. Nunes, Cláudia Seabra, Catarina Leal Pharmaceuticals (Basel) Article The low solubility of active pharmaceutical ingredients (APIs) is a problem in pharmaceutical development. Several methodologies can be used to improve API solubility, including the use of eutectic systems in which one of the constituents is the API. This class of compounds is commonly called Therapeutic Deep Eutectic Systems (THEDES). THEDES has been gaining attention due to their properties such as non-toxicity, biodegradability, and being non-expensive and easy to prepare. Since the knowledge of the solid liquid diagram of the mixture and the ideal eutectic point is necessary to ascertain if a mixture is a deep eutectic or just a eutectic mixture that is liquid at ambient temperature, the systems studied in this work are called Therapeutic Liquid Eutectic Systems (THELES). Therefore, the strategy proposed in this work is to improve the solubility of chlorpropamide and tolbutamide by preparing THELES. Both APIs are sulfonylurea compounds used for the treatment of type 2 diabetes mellitus and have low solubility in water. To prepare the THELES, several coformers were tested, namely, tromethamine, L(+)-arginine, L-tryptophan, citric acid, malic acid, ascorbic acid, and p-aminobenzoic acid, in molar ratios of 1:1 and 1:2. To improve viscosity, water was added in different molar ratios to all systems. THELES were characterized by mid-infrared spectroscopy (MIR), and differential scanning calorimetry. Their viscosity, solubility, and permeability were also determined. Their stability at room temperature and 40 °C was accessed by MIR. Cytocompatibility was performed by metabolic activity and cell lysis evaluation, according to ISO10993-5:2009, and compared with the crystalline APIs. THELES with TRIS were successfully synthesized for both APIs. Results showed an increased solubility without a decrease in the permeability of the APIs in the THELES when compared with the pure APIs. The THELES were also considered stable for 8 weeks at ambient temperature. The cells studied showed that the THELES were not toxic for the cell lines used. MDPI 2022-02-23 /pmc/articles/PMC8951776/ /pubmed/35337077 http://dx.doi.org/10.3390/ph15030279 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Sarraguça, Mafalda C.
Ribeiro, Paulo R. S.
Nunes, Cláudia
Seabra, Catarina Leal
Solids Turn into Liquids—Liquid Eutectic Systems of Pharmaceutics to Improve Drug Solubility
title Solids Turn into Liquids—Liquid Eutectic Systems of Pharmaceutics to Improve Drug Solubility
title_full Solids Turn into Liquids—Liquid Eutectic Systems of Pharmaceutics to Improve Drug Solubility
title_fullStr Solids Turn into Liquids—Liquid Eutectic Systems of Pharmaceutics to Improve Drug Solubility
title_full_unstemmed Solids Turn into Liquids—Liquid Eutectic Systems of Pharmaceutics to Improve Drug Solubility
title_short Solids Turn into Liquids—Liquid Eutectic Systems of Pharmaceutics to Improve Drug Solubility
title_sort solids turn into liquids—liquid eutectic systems of pharmaceutics to improve drug solubility
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8951776/
https://www.ncbi.nlm.nih.gov/pubmed/35337077
http://dx.doi.org/10.3390/ph15030279
work_keys_str_mv AT sarragucamafaldac solidsturnintoliquidsliquideutecticsystemsofpharmaceuticstoimprovedrugsolubility
AT ribeiropaulors solidsturnintoliquidsliquideutecticsystemsofpharmaceuticstoimprovedrugsolubility
AT nunesclaudia solidsturnintoliquidsliquideutecticsystemsofpharmaceuticstoimprovedrugsolubility
AT seabracatarinaleal solidsturnintoliquidsliquideutecticsystemsofpharmaceuticstoimprovedrugsolubility